agºÍ¼Ç

À´Ô´£ºÒþÐÎÑÛ¾µÓ¢ÎÄ  £¬×÷Õߣº  £¬£º

¶ªÄÇÐÇ  £¬½²µ½´ºÔ˾ÍÂÑÈÈÄÖ  £¬³Ã÷ÈÕ¾ÀïÈ˼·µ½ÂѶ¼µø  £¬Æ±¸ü×ÓÄÑÇÀ¡£ÄãÏþµÃû  £¬Õâô¶àÄêÏÂÀ´  £¬´ºÔ˶¼¸ãµÃÏñ¹ýÄêÒ»ÑùÈÈÄÖ  £¬³Ã÷ÈվЧÀÍÒ²ÊÇÓиïеÄ¡£×î½üÌý˵Óиö¡°Ý¸Ê½Ð§Àͱê×¼¡±  £¬ËµÊǽ²¾¿Ï¸ÖÂÖܵ½  £¬´ºÔËÆÚ¼äÒ²ÄÜÈÃÈËÊæ·þЩ¡£¾¿¾¹¸ü×Ó»ØÊ £¿ÔÛÁÄÁÄ¿´¡£

ݸʽЧÀͱê×¼ÊÇʲô¹í £¿

ุúÄ㽲࣠ £¬Õâ¸öݸʽЧÀͱê×¼  £¬¾ÍÊǹ㶫¶«Ý¸ÄDZ߸ã³öÀ´µÄЧÀÍÀíÄ˵°×ÁË  £¬¾ÍÊÇЧÀ͵½Î»  £¬Ï¸ÖµÃÂѶ¼Ìô²»³ö벡  £¬¿Í»§ÌåÑéÒªÂѺ᣾ÙÀý࣠ £¬Ïñ³Ã÷ÈÕ¾ÀïɶָÒýÅÆ¡¢ºò³µÌüµÄÇé¿ö¡¢ÁíÓÐÊÂÇéÈËԱ̬¶È  £¬¶¼µÃ¸ãµÃÂéÖ±Êæ·þ  £¬Ã»È»Ä㿴מÍÏñµô¹«¹êÒ»ÑùÄÑÊÜ¡£

ÄãÔÙ½²µ½¹ðÁøÕâ±ß  £¬´ºÔËʱÄܲ»¿É¸ã³öÕâÖÖ±ê×¼ £¿ÎÒ¹À¶Ñ  £¬¸ãÂÑû¼û¡£ÄãÏþµÃ´ºÔËÈ˶à  £¬³Ã÷ÈÕ¾ÀïÒ»¶ÑÈËÏñÆßºÚ°ËºÚµÄÂìÒÏÒ»ÑùÂÒ´Ü  £¬ÏëÌåÑéʲô±ê׼ЧÀÍ  £¬ÂÑ»ðÌÌ¡£¸ü×Ó½²  £¬ßÖÓÐЩµØ·½¶¼Ã»µÃµØ·½×ø  £¬½ÐÄñ¶¼²»ÏþµÃÈ¥ÄÄ¿­¡£³Ã÷ÈÕ¾ÀïÄÇÊÂÇéÈËÔ±  £¬½²ÆðÀ´¿ÉÄÜ̬¶ÈÂÑ»¹¿ÉÒÔ  £¬µ«Ã¦µ½ÂÑ·ÉÆðÀ´  £¬ÄãÏëҪɶϸÖÂЧÀÍ £¿ÂÑë»Ò£¡

Ïà¹ØÍ¼Æ¬

¹ðÁø´ºÔËЧÀÍÄܵð¸Üµ½ÄÄÀï £¿

í¥×Ó½²à£  £¬Æäʵ¹ðÁøÕâ±ß´ºÔËЧÀÍÒ²²»ÊÇÍêȫû¸ãÍ·¡£ÓÐЩ³Ã÷ÈÕ¾ÕÕ¾ÉÓеã¸ã·¨  £¬ºÃ±Èºò³µÌüÕ⼸Äê¸ãµÃ¿í³¨ÁËЩ  £¬È˼·µÃûÄÇôÂÑ»ðÌÌ¡£ÁíÍâ  £¬ÏñƱÎñ´°¿ÚÓÐЩµØ·½Ò²¿ª¶àÁË¡£ÔÙ½²µ½¶¯³Ã÷ÈÕ¾  £¬ÄÇЩµç×ÓÆÁĻָÒý»¹ËãÐÑÁú  £¬ÎÊ·ûÄÇôÐÁ¿à¡£²»¹ýÄãҪ˵ݸʽ±ê×¼ÄÇÖÖϸÖµ½ÂÑÌô²»³ö벡µÄ  £¬ÎÒ¹À¶Ñ»¹²îµã¡£

ÐÑÁúµã£º ´ºÔËÆÚ¼äÄã×îºÃÌáǰ¿Ë³Ã÷ÈÕ¾  £¬Ã»È»ÂѼ·µÃÁ¬Õ¾¶¼ÕÒ²»×Å¡£ÁíÓÐ  £¬´øµã¸ÉÁ¸  £¬¹ðÁø³Ã÷ÈÕ¾Àï³ÔµÄ¹¤¾ßÂѹó  £¬ÂѺóÔҲû¼¸¸ö¡£

´ºÔËÆÚ¼äЧÀ͸ÄÉÆÓиãÍ·Â𠣿

à¸ÄãÌýÎÒ½²à£  £¬Õ⼸Äê¹ðÁø³Ã÷ÈÕ¾¸ãÁËһЩл¨Ñù¡£Ïñ¹ðÁÖÕ¾ÄÇЩ־ԸÕßЧÀÍ¶Ó  £¬ÒÂןìÂí¼×  £¬ÈÈÐĵÃÏñÈý½ÅèһÑùËæ´¦ÅÜ  £¬×ÊÖúָ·¡¢°áÐÐÀî  £¬»¹ËãÓиã¡£ÁøÖÝÕâ±ßÒ²ÓÐЩµØ·½¸ãÁË×ÔÖúЧÀÍÉ豸  £¬ÂòƱ¡¢È¡Æ±¶¼±ãµ±Ð©¡£½²µ½ÕâÀï  £¬¸ÐÊÜЧÀÍÕÕ¾ÉÓеã¸ïР £¬µ«ÒªËµÝ¸Ê½Ð§ÀÍÄÇÖÖϸÖµ½ÂÑÃ͵Äˮƽ  £¬»¹µÃŬŬÁ¦¡£


Ïà¹ØÍ¼Æ¬

ÄǾ¿¾¹´ºÔËÆÚ¼ä¹ðÁø³Ã÷ÈÕ¾ÄÜÌåÑ鵽ݸʽЧÀͱê×¼Â𠣿ÂÑÓö¼Ã»£¡Äã¾Í¼Ç×ÅÒ»µã£ºÌáǰ¿Ë³Ã÷ÈÕ¾  £¬´øºÃ¹¤¾ß  £¬±ð¸úÈ˼·³Éðò×ÓéK  £¬²ÅûÄÇôÂÑ»ðÌÌ¡£

Ïà¹ØÍ¼Æ¬

´ºÔËЧÀÍ, ݸʽЧÀͱê×¼, ¹ðÁø³Ã÷ÈÕ¾, ´ºÔËÌåÑé, ЧÀ͸ÄÉÆ

¡¶³üÖݱ±Õ¾ËÄÖÜ30ÔªµÄÂùÝÓÐÄÄЩ¡·

×÷ΪҵÄÚ½ÏÔç½á¹¹×ªÐÍµÄÆóÒµ  £¬Íò¿Æ¾­ÓªÐ§ÀÍÒµÎñµÄÓªÊÕÌåÏÖÎȽ¡¡£½ØÖ¹2025ÄêÈý¼¾¶È  £¬Íò¿Æ¾­ÓªÐ§ÀÍÒµÎñʵÏÖÊÕÈë?435.7?ÒÚÔª  £¬Í¬±È¼á³ÖƽÎÈ  £¬³¤×âÒµÎñ¹æÄ£¡¢Ð§ÂʺÍÄɱ£Á¿¼á³ÖÐÐÒµµÚÒ»  £¬ÖÎÀí¹æÄ£Í»ÆÆ20Íò¼ä  £¬³ö×âÂÊÎȶ¨ÔÚ94%¡£ÎïÒµÒµÎñÉϰëÄêÔÚ¹ÜסլÎïÒµÏîÄ¿³¬4400¸ö  £¬ÉÌÆóÎïҵЧÀÍÏîÄ¿³¬2500¸ö  £¬¹æÄ£Óë×ÛºÏЧÀÍÄÜÁ¦ÒµÄÚÁìÏÈ¡£ÎïÁ÷ÒµÎñǰÈý¼¾¶È¿É×âÁÞ²Ö´¢Ãæ»ý³¬1000Íòƽ·½Ã×  £¬²Ö´¢¹æÄ£Î»ÁÐÐÐÒµµÚÒ»ÌÝ¶Ó  £¬ÀäÁ´ÒµÎñÐÐÒµ¹æÄ£µÚÒ»  £¬¸ß±ê²Ö´¢ÎȰ´ÆÚ³ö×âÂÊ?86%  £¬³ö×âÂʼá³ÖÐÐÒµ½Ï¸ßˮƽ£»ÉÌÒµÒµÎñ¿ÍÁ÷¡¢ÏúÊÛÎȲ½Ôö³¤  £¬ÕûÌå³ö×âÂÊ92%¡£

¡¶ÞÖÅ®VA88¡·

²»¿ÉÊÇ»ØÓ¦OpenAI½üÆÚµÄÓßÂÛ  £¬Ò²ÊÇΪͶ×ÊÕßÃÇ´ò϶¨ÐļÁ  £¬¡°AI²»ÊÇÅÝÄ­  £¬OpenAIÖµµÃͶ×Ê¡±¡£

¡¶ÃÀÅ®µÄ±Æ±Æ¡·

[3]Inside the C-Suite£ºPharma leaders share their vision for AI.

ÍøÕ¾µØÍ¼